- Home
- GNFT vs ARTV Comparison
GNFT vs ARTV Comparison
Compare GNFT & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- ARTV
- Stock Information
- Founded
- GNFT 1999
- ARTV 2019
- Country
- GNFT France
- ARTV United States
- Employees
- GNFT N/A
- ARTV N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- ARTV
- Sector
- GNFT Health Care
- ARTV
- Exchange
- GNFT Nasdaq
- ARTV NYSE
- Market Cap
- GNFT 211.1M
- ARTV 232.8M
- IPO Year
- GNFT 2019
- ARTV 2024
- Fundamental
- Price
- GNFT $4.34
- ARTV $11.90
- Analyst Decision
- GNFT Strong Buy
- ARTV Strong Buy
- Analyst Count
- GNFT 1
- ARTV 5
- Target Price
- GNFT $13.00
- ARTV $21.25
- AVG Volume (30 Days)
- GNFT 4.6K
- ARTV 79.3K
- Earning Date
- GNFT 09-19-2024
- ARTV 08-29-2024
- Dividend Yield
- GNFT N/A
- ARTV N/A
- EPS Growth
- GNFT N/A
- ARTV N/A
- EPS
- GNFT N/A
- ARTV N/A
- Revenue
- GNFT $38,115,397.00
- ARTV $29,256,000.00
- Revenue This Year
- GNFT $171.45
- ARTV N/A
- Revenue Next Year
- GNFT N/A
- ARTV N/A
- P/E Ratio
- GNFT N/A
- ARTV N/A
- Revenue Growth
- GNFT 31.38
- ARTV 493.31
- 52 Week Low
- GNFT $2.89
- ARTV $9.71
- 52 Week High
- GNFT $6.05
- ARTV $16.00
- Technical
- Relative Strength Index (RSI)
- GNFT 54.93
- ARTV N/A
- Support Level
- GNFT $3.90
- ARTV N/A
- Resistance Level
- GNFT $4.45
- ARTV N/A
- Average True Range (ATR)
- GNFT 0.25
- ARTV 0.00
- MACD
- GNFT 0.01
- ARTV 0.00
- Stochastic Oscillator
- GNFT 80.51
- ARTV 0.00
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.